金彩汇

Research and Innovation at Amoytop Biotech
Home / Research and Innovation

Research and Innovation at Amoytop Biotech

Since its establishment, Amoytop Biotech has been focusing on recombinant protein medicines and their long-acting modification. After continuous building and improving its R&D team and R&D system, Amoytop Biotech’s functional modules, including R&D Center, Medical Development Center, Manufacturing Center and Quality Center, are able to cover every step in the R&D of innovative drugs, from scientific discovery, laboratory trial, pilot trial, preclinical and clinical trial to industrialization. 

Research and Innovation

  • Insisting on constant innovation and development, Amoytop Biotech has built up a research and development team for therapeutic recombinant proteins and relevant long-acting modified innovative drugs, which was selected as the "Innovation Team in Priority Fields" of the Ministry of Science and Technology. Since the 11th five-year plan, this team has undertaken nine projects of Significant New Drugs Development, which are National Major Scientific and Technological Special Projects; The team has been participating in three sub-projects under the National Science and Technology Major Project for Innovative Drug Development, securing seven Class 1 new drugs either already launched or currently in clinical trials.

    Amoytop Biotech owns a professional research and development center—Xiamen Biosteed Gene Transformation Tech. Co., Ltd. Meanwhile, it has established a postdoctoral research station and national-local joint research center, possessing sufficient talent reserves to make breakthroughs in core technologies.

Main Pipelines

Facebook
Twitter
LinkedIn
Instagram

WELCOME

Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Leave a Message
Get In Touch